Krs Pharmaceuticals Private Limited, a active private limited company, was established on 12 September 2000 in Hyderabad, Telangana, India. Engaging in api manufacturers within the hospital and medical care sector, it holds CIN: U24239TG2000PTC035234. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹8.46 Cr and a paid-up capital of ₹6.73 Cr.
It upholds a compliant status. Employing 55 professional, Its leadership includes Lakshmana Swamy Balusu (Managing Director), Narendra Balusu (Director), Sai Phani Teja Balusu (Director). Past directors included Surapanani Veera Kumar Das. It holds ₹22.51 Cr open charges and ₹9.55 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.44, Co-Operative Industrial Estate Gandhi Nagar, Balanagar, Hyderabad, Telangana, 500037.
U24239TG2000PTC035234
035234
12 September 2000
₹8.46 Cr
₹6.73 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Krs Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmana Swamy Balusu | Managing Director | 12 Sep 2000 | Current |
| Narendra Balusu | Director | 27 Aug 2004 | Current |
| Sai Phani Teja Balusu | Director | 13 Oct 2021 | Current |
| Koneru Chiranjivee Rammohan Rao | Director | 02 Nov 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Krs Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.02% decrease. The company also saw a substantial fall in profitability, with a 76.86% decrease in profit. The company's net worth moved up by a moderate rise of 1.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Krs Pharmaceuticals had a promoter holding of 84.09% and a public holding of 15.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹225,110,455.00
₹95,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2023 | Others | ₹4.98 Cr | Open |
| 27 Jun 2023 | Others | ₹9.10 Cr | Open |
| 29 Sep 2020 | Axis Bank Limited | ₹1.43 M | Open |
| 22 Feb 2018 | Others | ₹8.29 Cr | Open |
| 12 Jan 2009 | State Bank Of India | ₹8.56 Cr | Satisfied |
Explore comprehensive loan charge details -
Krs Pharmaceuticals has a workforce of 55 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Krs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krs Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 9.10 Cr registered on 27 Jun 2023 with Charge ID 100766026 was modified on 31 Jan 2025. was recorded as a recent event.
Krs Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Krs Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 4.98 Cr with Charge ID 100872415 was registered on 29 Dec 2023. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 9.10 Cr with Charge ID 100766026 was registered on 27 Jun 2023. was completed.
Sai Phani Teja Balusu was appointed as a Director was appointed as a Director on 13 Oct 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.
The CIN of Krs Pharmaceuticals Private Limited is U24239TG2000PTC035234.
Krs Pharmaceuticals Private Limited is headquartered at Plot No.44, Co-Operative Industrial Estate Gandhi Nagar, Balanagar, Hyderabad, Telangana, 500037.
Krs Pharmaceuticals Private Limited was incorporated on 12 September 2000.
The current directors of Krs Pharmaceuticals Private Limited are
The primary industry of Krs Pharmaceuticals Private Limited is Hospital And Medical Care.
Krs Pharmaceuticals Private Limited is unlisted.
The authorized capital of Krs Pharmaceuticals Private Limited is ₹8.46 Cr, and the paid-up capital is ₹6.73 Cr.
The compliance status of Krs Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX